Navigation Links
Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
Date:8/7/2008

SAN RAMON, Calif., Aug. 7 /PRNewswire/ -- Odyssey Thera, Inc. announced that it has received a milestone payment from Pfizer Inc, following Pfizer's decision to progress a discovery stage drug candidate into pre-clinical development. The drug candidate was extensively studied by Odyssey Thera as part of the ongoing collaboration with Pfizer.

"We are very pleased with the progress of the collaboration with Pfizer," said John K. Westwick, Ph.D., Odyssey Thera's President and CEO. "Progress on this and other discovery programs with Pfizer demonstrates the power of our unique cellular analysis platform to improve knowledge of drug mechanisms and selectivity."

In August 2006, Odyssey Thera announced its third alliance with Pfizer. Under the terms of the multi-year agreement, Odyssey Thera is collaborating on multiple Pfizer drug discovery projects, and has received upfront payments, research and capital expenditure funding, and previous success-based milestones. The achievement of this milestone announced today is the Company's first such milestone to be earned for contributing to the advancement of a drug candidate.

About Odyssey Thera, Inc.

Odyssey Thera's patented technology measures disease-relevant pathway activity within living human cells. Rapid identification of on-target and off-pathway activities of lead compounds enables selection of drug candidates with favorable safety and selectivity profiles. Odyssey is leveraging its proprietary drug discovery and development platform for internal programs and for premier pharmaceutical company partners.

To learn more about Odyssey Thera, please visit http://www.odysseythera.com


'/>"/>
SOURCE Odyssey Thera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network
2. Odyssey Thera Granted U.S. Patent for Animal Imaging
3. Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
4. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
5. VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress
6. CV Therapeutics Reports 2008 Second Quarter Financial Results
7. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
8. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
9. Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement
10. United Therapeutics Reports Second Quarter 2008 Financial Results
11. Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ilable in German . , Whether it,s CD packag... (Radio Frequency Identification) are increasingly...t possible to label objects or goods and identify ...iate scanner can read and process the data contain...ods under production conditions of up to 100 degre...
(Date:11/24/2009)... The New York investment bank KTA Capital,s cli...d an AU$6.7 mil convertible note private placement...lacement was arranged by KTA Capital as Neuren,s e... New York (PRWEB) November 23, 2009 ...pital, LLC ("KTA Capital") has announced...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced that it has received notice fro...any,s common stock will be,suspended as of Novembe...e,Securities and Exchange Commission, which will r..., unless the company files an appeal to the Nasdaq...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced the approval of all of its,"fir...he District of Delaware,(the "Bankruptcy Court"). ...lief under Chapter 11 of the United States Bankrup... orders issued by the Bankruptcy Court allow the c...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...poration (NYSE: SGP ) will hold its Annual Meeti...cago at 7:30 a.m. (CDT) (8:30 a.m. EDT). On that ...le to all interested parties via the corporate Web...nual Meeting, Fred Hassan, chairman and CEO, will ...e and progress. , , The proposed combination wit...
...oration (NYSE: BSX ) today announced the schedul...ents at the 30th Annual Scientific Sessions of the... in Boston. Highlights of the week,s events inclu...T II clinical trial and the ALTITUDE Clinical Scie... insights for implantable cardioverter defibrillat...
...ll/ -- American Oriental,Bioengineering, Inc. (NYS...improving health through the development, manufact...cription and over the counter ("OTC") products in ...rst quarter ended March 31, 2009. , Financial ... increased 18.9% year over year to,$46.1 million f...
Other Biology Technology:Schering-Plough Schedules Webcast For Annual Meeting of Shareholders 2Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 2Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 3Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 4Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 5American Oriental Bioengineering Reports First Quarter 2009 Financial Results 2American Oriental Bioengineering Reports First Quarter 2009 Financial Results 3American Oriental Bioengineering Reports First Quarter 2009 Financial Results 4American Oriental Bioengineering Reports First Quarter 2009 Financial Results 5American Oriental Bioengineering Reports First Quarter 2009 Financial Results 6American Oriental Bioengineering Reports First Quarter 2009 Financial Results 7
(Date:11/24/2009)...ATON ROUGE Antarctica has long held secrets of th...til recently, there has been very little informati...th miles of ice for millions of years. Now, a team...LSU have been funded to the tune of $10 million d... to get to the bottom of things literally. These ...
(Date:11/23/2009)...hington, D.C. The community-associated strain of ...ria resistant to most common antibioticsposes a fa...is making its way into hospitals, according to a s... Diseases . , The new threat is easily picked u...aces and has increased the overall burden of MRSA ...
(Date:11/23/2009)...mington, CT Current research suggests that a comm...e. The related report by Nichols et al, "Unique L...w Class of TLR2 Ligands Capable of Enhancing Autoi...e American Journal of Pathology . , Multiple sc...tacks the brain and spinal cord, affects nearly 1 ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Sinovac Schedules 2008 Annual General Meeting 48447 1Sinovac Schedules 2008 Annual General Meeting 48447 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 1The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 1American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 2American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 4
...ce later this week, it will take along three kinds...etic responses and their ability to cause disease ... STS-115 space shuttle mission scheduled for launc...-- Salmonella typhimurium, Pseudomonas aeruginosa ...as potential threats to crew health. Sending these...
... System have shown for the first time that getting... cells can reverse myotonic dystrophy, the most co...t 40,000 people in the United States have myotonic... slow, progressive wasting of the muscles, irregul...ny people don,t know they have MMD until their tee...
...ins in Tanzania revealed over 160 animal species--... species--according to an article published in the...gs elevate the importance of protecting this biolo...rn Arc Mountain range from destructive activities ...gging and poaching. , "The wealth of life that,s s...
Other Biology News:Microscopic passengers to hitch ride on space shuttle 2Microscopic passengers to hitch ride on space shuttle 3Toxic molecule may cause most common type of muscular dystrophy 2First surveys of Tanzanian mountains reveal 160+ animal species, including new & endemic 2
Adipocyte Lipolysis Colorimetric Assay Kit from Zen-Bio, Inc.
Strip Cap Tool from Bio-Rad
EZ-Retriever System from BioGenex
Calcium Flux Antagonist Chip, 4-Sipper (coated) from Caliper Life Sciences
Biology Products: